Trials / Sponsors / Adicet Therapeutics
Adicet Therapeutics
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1 Study of ADI-001 in Rheumatoid Arthritis Rheumatoid Arthritis (RA) | Phase 1 | 2025-10-10 |
| Active Not Recruiting | A Phase 1/2 Trial of ADI-270 in ccRCC Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2024-12-12 |
| Enrolling By Invitation | A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease Lupus Nephritis, Autoimmune Diseases, Systemic Sclerosis (SSc) | Phase 1 | 2024-11-10 |
| Active Not Recruiting | Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma | — | 2022-02-14 |
| Terminated | A Phase 1 Study of ADI-001 in B Cell Malignancies Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma | Phase 1 | 2021-03-04 |